Propofol vs etomidate on haemodynamic parameters during ProsSeal laryngeal mask insertio
Not Applicable
Not yet recruiting
- Conditions
- Hemodynamic response during airway insertion
- Registration Number
- SLCTR/2017/038
- Lead Sponsor
- Vinayaka Missions Medical College
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Not specified
- Target Recruitment
- Not specified
Inclusion Criteria
1. Male and female adults (>18 years)
2. American society of Anaesthesiologists physical status classes I and II,
3. Normal airway
4. Undergoing elective surgeries of short duration (1 hour or less)
Exclusion Criteria
1. Full stomach
2. Emergency surgery
3. Significant cardiorespiratory illness
4. Bowel surgeries
5. Laparoscopic surgeries
6. Difficult airway
7. Known allergy to study drugs
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie etomidate's hemodynamic effects during ProSeal LMA insertion?
How does etomidate compare to propofol in managing hemodynamic responses during airway procedures in clinical practice?
Are there specific biomarkers that predict patient response to etomidate or propofol in airway insertion scenarios?
What are the potential adverse events associated with etomidate versus propofol in hemodynamic management?
What alternative anesthetic agents or combination therapies are being explored for hemodynamic stability during LMA insertion?